🇺🇸 FDA
Pipeline program

TAK-188

TAK-188-1501

Phase 2 small_molecule active

Quick answer

TAK-188 for Advanced or Metastatic Solid Tumors is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Advanced or Metastatic Solid Tumors
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials